HIGHLIGHTS
- who: Michael Kasperkiewicz from the University of Alberta, Canada have published the research: Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study, in the Journal: (JOURNAL)
- what: Further knowledge regarding COVID19 vaccination and AIBDs has been gained since the publication of the study by Maronese et_al (6).
- how: The authors declare that the research was conducted in the absence of any commercial or financial relationships
- future: While additional well-designed investigations on this controversial topic are required SARS-CoV-2 vaccination in AIBD patients should be generally encouraged . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.